#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3908	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2348	483.7	0	.	n	.	0	C207T	SNP	207	207	C	557	557	T	499	T,C,A	199,239,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3908	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2348	483.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1534	1534	C	567	C	516	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3908	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2348	483.7	0	HET	.	.	.	C451T,A	.	451	451	C	801	801	C	486	C,T,A	221,210,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3908	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2348	483.7	0	HET	.	.	.	C328G	.	328	328	C	678	678	C	496	C,G	342,110	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3908	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2348	483.7	0	HET	.	.	.	C1450T,A,G	.	1450	1450	C	1800	1800	C	630	C,T,A,G	300,280,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4498	411.9	0	.	n	.	0	T695C	SNP	695	695	T	1584	1584	C	450	C,A	394,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4498	411.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2860	2860	C	558	C,A	498,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4498	411.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3486	3486	T	566	T,A,G	503,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6182	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4498	411.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2934	2934	A	574	A,G	520,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	612	folP	855	855	100.0	folP.l6.c17.ctg.1	2160	84.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1314	1316	AGC	119;119;120	A;G;C	103;108;105	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1212	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3956	91.7	1	SNP	p	S91F	1	.	.	271	273	TTC	750	752	TTC	110;110;110	T;T;C	100;102;99	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1212	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3956	91.7	1	SNP	p	G95N	0	.	.	283	285	GGC	762	764	GGC	108;108;108	G,T;G;C	97,1;99;98	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1212	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3956	91.7	1	SNP	p	D95G	1	.	.	283	285	GGC	762	764	GGC	108;108;108	G,T;G;C	97,1;99;98	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	620	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1871	99.2	1	SNP	p	G45D	0	.	.	133	135	GGC	736	738	GGC	160;160;160	G;G;C,G	141;140;141,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	394	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1336	87.4	0	.	n	.	0	A197.	DEL	197	197	A	694	694	A	151	A	139	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3556	131.6	1	SNP	p	D86N	0	.	.	256	258	GAC	925	927	GAC	150;150;151	G,C;A,C;C,A	136,1;128,2;136,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3556	131.6	1	SNP	p	R87I	0	.	.	259	261	CGT	928	930	CGT	151;151;150	C,A;G;T,A	133,2;136;135,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3556	131.6	1	SNP	p	S87R	1	.	.	259	261	CGT	928	930	CGT	151;151;150	C,A;G;T,A	133,2;136;135,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3556	131.6	1	SNP	p	R87W	0	.	.	259	261	CGT	928	930	CGT	151;151;150	C,A;G;T,A	133,2;136;135,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1560	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3556	131.6	1	SNP	p	S88P	0	.	.	262	264	TCC	931	933	TCC	150;150;150	T;C;C	135;138;136	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1054	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3225	97.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1848	1850	GGC	120;119;119	G;G,C;C	111;109,1;108	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1463	1465	GCC	140;142;142	G;C,A;C	134;127,1;133	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1466	1468	ATG	143;144;144	A;T;G	136;133;129	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1478	1480	ACC	147;147;146	A;C,A;C,T,A	135;127,1;134,1,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1478	1480	ACC	147;147;146	A;C,A;C,T,A	135;127,1;134,1,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1979	1981	ACC	140;140;140	A;C;C	126;125;120	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2033	2035	GCG	143;143;142	G;C;G	121;122;124	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2033	2035	GCG	143;143;142	G;C;G	121;122;124	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2156	2158	GGT	134;133;132	G,T;G;T	123,1;125;124	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2165	2167	AGC	133;133;135	A;G;C	126;124;124	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1028	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2812	109.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2183	2185	CCG	139;140;139	C,G;C;G,C	112,1;118;110,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1472	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3582	123.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1854	1856	CCG	157;158;159	C;C;G	132;135;135	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	766	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2269	100.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	818	818	C	115	C	106	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1501	23.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1228	1230	AAT	21;21;21	A;A;T,C	20;20;17,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1501	23.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1231	1233	AAT	21;21;21	A;A;T	20;20;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1501	23.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1255	1257	GCA	20;20;20	G;C;A	19;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1501	23.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1278	1280	GTA	18;18;18	G;T;A	18;17;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	128	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1501	23.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1287	1287	A	17	A	17	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	808	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	2297	104.4	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1171	1173	AGA	171;170;169	A;G;A	159;157;156	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	808	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	2297	104.4	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1192	1194	GGT	170;170;170	G;G;T	159;160;161	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	808	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	2297	104.4	1	SNP	p	G120K	1	.	.	358	360	AAG	901	903	AAG	165;165;165	A;A;G	145;145;135	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	808	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	2297	104.4	1	SNP	p	N121D	0	.	.	361	363	AAC	904	906	AAC	167;166;166	A,G;A;C,A	140,1;145;145,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	808	porB1b	1038	1038	99.81	porB1b.l6.c17.ctg.1	2297	104.4	1	SNP	p	A121N	1	.	.	361	363	AAC	904	906	AAC	167;166;166	A,G;A;C,A	140,1;145;145,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2560	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5483	140.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	466	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1620	86.2	1	SNP	p	V57M	1	.	.	169	171	ATG	865	867	ATG	155;157;159	A;T;G	146;143;145	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
